Michal Smida (Michal Šmída)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Atomic Force Microscopy

Top Venues

International journal of molecular sciences

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Aneta Ledererova, Lenka Dostalova, Veronika Kozlova, Helena Peschelova, Adriana Ladungova, Martin Culen, Tomas Loja, Jan Verner, Sarka Pospisilova, Michal Smida, Veronika Mančíková
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro. Journal for immunotherapy of cancer 9 (8) (2022)
Magdalena Skalníková, Kateřina Staňo Kozubík, Jakub Trizuljak, Zuzana Vrzalová, Lenka Radová, Kamila Réblová, Radka Holbová, Terézia Kurucová, Hana Svozilová, Jiří Štika, Ivona Blaháková, Barbara Dvořáčková, Marie Prudková, Olga Stehlíková, Michal Smida, Leoš Křen, Petr Smejkal, Sarka Pospisilova, Michael Doubek
A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome. International journal of molecular sciences 23 (2) (2022)
Veronika Mancikova, Michal Smida
Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia. International journal of molecular sciences 22 (11) (2021)
Veronika Kozlova, Aneta Ledererova, Adriana Ladungova, Helena Peschelova, Pavlina Janovska, Aleksander Slusarczyk, Joanna Domagala, Pavel Kopcil, Viera Vakulova, Jan Oppelt, Vitezslav Bryja, Michael Doubek, Jiri Mayer, Sarka Pospisilova, Michal Smida
CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells. PloS one 15 (3) (2020)